descriptionPublicationkeyboard_double_arrow_right Article 01 Aug 2017 English Publisher:Elsevier BVJournal:Pediatric Clinics of North America, volume 64, pages 937-951 (issn: 0031-3955,

Authors: Debbie-Ann T, Shirley; James P, Nataro;

doi: 10.1016/j.pcl.2017.03.012

pmid: 28734519

Zika Virus Infection

- Summary
- Subjects
- Metrics

Abstract

In less than 2 years since entry into the Americas, we have witnessed the emergent spread of Zika virus into large subsets of immunologically naïve human populations and then encountered the devastating effects of microcephaly and brain anomalies that can arise from in utero infection with the virus. Diagnostic evaluation and management of affected infants continues to evolve as our understanding of Zika virus rapidly advances. The development of a safe and effective vaccine holds the potential to attenuate the spread of infection and limit the impact of congenital infection.

Related Organizations

University of Virginia
United States

Keywords

Zika Virus Infection, Infant, Zika Virus, Antiviral Agents, Vaccines, Inactivated, Pregnancy, Microcephaly, Humans, Female, Pregnancy Complications, Infectious

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	11
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%